Logo
Logo

Explore Anti-Diabetic Products

Dapagliflozin (PG Solvate Monohydrate)

Anti-Diabetic

Dapagliflozin (Amorphous)

Anti-Diabetic

Glimepiride

Anti-Diabetic

Linagliptin

Anti-Diabetic

Liraglutide

Anti-Diabetic

Pioglitazone Hydrochloride

Anti-Diabetic

Sitagliptin Hydrochloride

Anti-Diabetic

We stay committed to ensuring that we continue to provide high-quality and safe APIs to our partners

We offer:

  • End to end solutions
  • Best in class quality
  • cGMP manufacturing capacities
  • Continuous process innovation
  • Back-ward integration
  • Consistent supply on a commercial scale.
  • Regulatory and early launch advantage

Explore other Therapeutic categories.

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.